Literature DB >> 9462564

Therapeutic options in patients with obstructive hypertrophic cardiomyopathy and severe drug-refractory symptoms.

L Fananapazir, D McAreavey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9462564     DOI： 10.1016/s0735-1097(97)00509-3

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  6 in total

Review 1.  Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathy.

Authors:  Mohammed Qintar; Abdulrahman Morad; Hazem Alhawasli; Khaled Shorbaji; Belal Firwana; Adib Essali; Waleed Kadro
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

2.  Dynamic morphology of the secundum atrial septal defect evaluated by three dimensional transoesophageal echocardiography.

Authors:  Y V Maeno; L N Benson; P R McLaughlin; C Boutin
Journal:  Heart       Date:  2000-06       Impact factor: 5.994

3.  DDDR pacing for symptomatic patients with hypertrophic obstructive cardiomyopathy: The first experience in the Netherlands with pacing in HOCM.

Authors:  H J Achterberg; M G Scheffer; R van Mechelen; M J M Kofflard; F J Ten Cate
Journal:  Neth Heart J       Date:  2002-06       Impact factor: 2.380

4.  Visualization of transcoronary ablation of septal hypertrophy in patients with hypertrophic obstructive cardiomyopathy: a comparison between cardiac MRI, invasive measurements and echocardiography.

Authors:  Christian Sohns; Samuel Sossalla; Jan D Schmitto; Claudius Jacobshagen; Björn W Raab; Silvia Obenauer; Lars S Maier
Journal:  Clin Res Cardiol       Date:  2010-02-21       Impact factor: 5.460

5.  Transcoronary ablation of septal hypertrophy for hypertrophic obstructive cardiomyopathy: feasibility, clinical benefit, and short term results in elderly patients.

Authors:  F H Gietzen; C J Leuner; L Obergassel; C Strunk-Mueller; H Kuhn
Journal:  Heart       Date:  2004-06       Impact factor: 5.994

6.  Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.

Authors:  Takashi Nakamura; Yoshitaka Iwanaga; Masakazu Yasuda; Takayuki Kawamura; Yuki Miyaji; Hanako Morooka; Shunichi Miyazaki
Journal:  Int J Cardiovasc Imaging       Date:  2015-11-20       Impact factor: 2.357
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.